These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

864 related items for PubMed ID: 30415774

  • 1. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
    Chea C, Miyauchi M, Inubushi T, Okamoto K, Haing S, Nguyen PT, Imanaka H, Takata T.
    Biochem Biophys Res Commun; 2018 Dec 09; 507(1-4):142-147. PubMed ID: 30415774
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
    Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI, Hong SP, Hong SD.
    J Exp Clin Cancer Res; 2009 Feb 26; 28(1):28. PubMed ID: 19243631
    [Abstract] [Full Text] [Related]

  • 3. Thymosin β4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma.
    Hong KO, Lee JI, Hong SP, Hong SD.
    Amino Acids; 2016 Jan 26; 48(1):117-27. PubMed ID: 26276576
    [Abstract] [Full Text] [Related]

  • 4. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F, Ye LJ, Wang FJ, Liu HF, Wang XL.
    Environ Toxicol; 2020 Oct 26; 35(10):1050-1057. PubMed ID: 32469461
    [Abstract] [Full Text] [Related]

  • 5. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
    Chaw SY, Abdul Majeed A, Dalley AJ, Chan A, Stein S, Farah CS.
    Oral Oncol; 2012 Oct 26; 48(10):997-1006. PubMed ID: 22704062
    [Abstract] [Full Text] [Related]

  • 6. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A, Masferrer E, Hernández-Ruiz ME, Ferrandiz-Pulido C, Yébenes M, Jaka A, Tuneu A, Jucglà A, Gimeno J, Baró T, Casado B, Gandarillas A, Costa I, Mojal S, Peña R, de Herreros AG, García-Patos V, Pujol RM, Hernández-Muñoz I.
    J Dermatol Sci; 2013 Nov 26; 72(2):93-102. PubMed ID: 23928229
    [Abstract] [Full Text] [Related]

  • 7. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L, Sun JJ, Cui YC, Jiang SL, Wang XW, Lv LY, Xie L, Song XR.
    Tumour Biol; 2016 Jul 26; 37(7):9979-87. PubMed ID: 26819207
    [Abstract] [Full Text] [Related]

  • 8. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
    Costa LC, Leite CF, Cardoso SV, Loyola AM, Faria PR, Souza PE, Horta MC.
    J Appl Oral Sci; 2015 Jul 26; 23(2):169-78. PubMed ID: 26018309
    [Abstract] [Full Text] [Related]

  • 9. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
    Yaginuma T, Gao J, Nagata K, Muroya R, Fei H, Nagano H, Chishaki S, Matsubara T, Kokabu S, Matsuo K, Kiyoshima T, Yoshioka I, Jimi E.
    Carcinogenesis; 2020 Aug 12; 41(8):1038-1048. PubMed ID: 31996896
    [Abstract] [Full Text] [Related]

  • 10. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
    Hu Y, He MY, Zhu LF, Yang CC, Zhou ML, Wang Q, Zhang W, Zheng YY, Wang DM, Xu ZQ, Wu YN, Liu LK.
    J Exp Clin Cancer Res; 2016 Jan 15; 35():12. PubMed ID: 26769084
    [Abstract] [Full Text] [Related]

  • 11. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC, Chung LC, Chen YJ, Feng TH, Juang HH.
    Cancer Lett; 2014 Dec 28; 355(2):242-52. PubMed ID: 25218595
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of E-cadherin and vimentin in oral squamous cell carcinoma.
    Zhou J, Tao D, Xu Q, Gao Z, Tang D.
    Int J Clin Exp Pathol; 2015 Dec 28; 8(3):3150-4. PubMed ID: 26045832
    [Abstract] [Full Text] [Related]

  • 14. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
    Angadi PV, Patil PV, Angadi V, Mane D, Shekar S, Hallikerimath S, Kale AD, Kardesai SG.
    Int J Surg Pathol; 2016 Dec 28; 24(8):696-703. PubMed ID: 27312520
    [Abstract] [Full Text] [Related]

  • 15. [Expression of Twist and relation with epithelial-mesenchymal transition in oral squamous cell carcinoma].
    Sun HX, Feng H, Song Y.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Oct 28; 33(5):534-8. PubMed ID: 26688951
    [Abstract] [Full Text] [Related]

  • 16. Curcumin Inhibits Invasiveness and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Through Reducing Matrix Metalloproteinase 2, 9 and Modulating p53-E-Cadherin Pathway.
    Lee AY, Fan CC, Chen YA, Cheng CW, Sung YJ, Hsu CP, Kao TY.
    Integr Cancer Ther; 2015 Sep 28; 14(5):484-90. PubMed ID: 26036622
    [Abstract] [Full Text] [Related]

  • 17. A Correlative Study of N-Cadherin Expression with Different Grades of Oral Squamous Cell Carcinoma Projecting as a Marker of Epithelial to Mesenchymal Transition in Tumor Progression.
    Rai K H, Ahmed J.
    Asian Pac J Cancer Prev; 2019 Aug 01; 20(8):2327-2332. PubMed ID: 31450902
    [Abstract] [Full Text] [Related]

  • 18. Relationship between TWIST expression and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma.
    Gao Y, Xuan XY, Zhang HY, Wang F, Zeng QR, Wang ZQ, Li SS.
    Cell Biol Int; 2012 Jun 01; 36(6):571-7. PubMed ID: 22360285
    [Abstract] [Full Text] [Related]

  • 19. Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma.
    Fan CC, Wang TY, Cheng YA, Jiang SS, Cheng CW, Lee AY, Kao TY.
    J Cancer Res Clin Oncol; 2013 Oct 01; 139(10):1735-44. PubMed ID: 23990016
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.